Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

EZH2 loss drives resistance to carboplatin and paclitaxel in serous ovarian cancers expressing ATM.

Naskou J, Beiter Y, van Rensburg R, Honisch E, Rudelius M, Schlensog M, Gottstein J, Walter L, Braicu EI, Sehouli J, Darb-Esfahani S, Staebler A, Hartkopf AD, Brucker S, Wallwiener D, Beyer I, Niederacher D, Fehm T, Templin MF, Neubauer H.

Mol Cancer Res. 2019 Nov 8. pii: molcanres.0141.2019. doi: 10.1158/1541-7786.MCR-19-0141. [Epub ahead of print]

PMID:
31704732
2.

Mouse Hepatomas with Ha-ras and B-raf Mutations Differ in Mitogen-Activated Protein Kinase Signaling and Response to Constitutive Androstane Receptor Activation.

Braeuning A, Kollotzek F, Zeller E, Knorpp T, Templin MF, Schwarz M.

Drug Metab Dispos. 2018 Nov;46(11):1462-1465. doi: 10.1124/dmd.118.083014. Epub 2018 Aug 16.

PMID:
30115646
3.

Peptide-Based Sandwich Immunoassay for the Quantification of the Membrane Transporter Multidrug Resistance Protein 1.

Poetz O, Dieze T, Hammer H, Weiß F, Sommersdorf C, Templin MF, Esdar C, Zimmermann A, Stevanovic S, Bedke J, Stenzl A, Joos TO.

Anal Chem. 2018 May 1;90(9):5788-5794. doi: 10.1021/acs.analchem.8b00152. Epub 2018 Apr 12.

PMID:
29570278
4.

A bead-based western for high-throughput cellular signal transduction analyses.

Treindl F, Ruprecht B, Beiter Y, Schultz S, Döttinger A, Staebler A, Joos TO, Kling S, Poetz O, Fehm T, Neubauer H, Kuster B, Templin MF.

Nat Commun. 2016 Sep 23;7:12852. doi: 10.1038/ncomms12852.

5.

Influence of Birch Bark Triterpenes on Keratinocytes and Fibroblasts from Diabetic and Nondiabetic Donors.

Wardecki T, Werner P, Thomas M, Templin MF, Schmidt G, Brandner JM, Merfort I.

J Nat Prod. 2016 Apr 22;79(4):1112-23. doi: 10.1021/acs.jnatprod.6b00027. Epub 2016 Mar 22.

PMID:
27002382
6.

Correction: EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.

Schneck H, Gierke B, Uppenkamp F, Behrens B, Niederacher D, Stoecklein NH, Templin MF, Pawlak M, Fehm T, Neubauer H; Disseminated Cancer Cell Network (DCC Net) Duesseldorf.

PLoS One. 2016 Feb 9;11(2):e0149315. doi: 10.1371/journal.pone.0149315. eCollection 2016. No abstract available.

7.

Tumor promotion and inhibition by phenobarbital in livers of conditional Apc-deficient mice.

Braeuning A, Gavrilov A, Geissler M, Wenz C, Colnot S, Templin MF, Metzger U, Römer M, Zell A, Schwarz M.

Arch Toxicol. 2016 Jun;90(6):1481-94. doi: 10.1007/s00204-016-1667-1. Epub 2016 Feb 2.

PMID:
26838046
8.

Coordinating Role of RXRα in Downregulating Hepatic Detoxification during Inflammation Revealed by Fuzzy-Logic Modeling.

Keller R, Klein M, Thomas M, Dräger A, Metzger U, Templin MF, Joos TO, Thasler WE, Zell A, Zanger UM.

PLoS Comput Biol. 2016 Jan 4;12(1):e1004431. doi: 10.1371/journal.pcbi.1004431. eCollection 2016 Jan.

9.

EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.

Schneck H, Gierke B, Uppenkamp F, Behrens B, Niederacher D, Stoecklein NH, Templin MF, Pawlak M, Fehm T, Neubauer H; Disseminated Cancer Cell Network (DCC Net) Duesseldorf.

PLoS One. 2015 Dec 22;10(12):e0144535. doi: 10.1371/journal.pone.0144535. eCollection 2015. Erratum in: PLoS One. 2016;11(2):e0149315.

10.

Bead-Based Peptide Arrays for Profiling the Specificity of Modification State-Specific Antibodies.

Filomena A, Beiter Y, Templin MF, Joos TO, Schneiderhan-Marra N, Poetz O.

Methods Mol Biol. 2015;1348:251-65. doi: 10.1007/978-1-4939-2999-3_22.

PMID:
26424278
11.

Indirect protein quantification of drug-transforming enzymes using peptide group-specific immunoaffinity enrichment and mass spectrometry.

Weiß F, Schnabel A, Planatscher H, van den Berg BH, Serschnitzki B, Nuessler AK, Thasler WE, Weiss TS, Reuss M, Stoll D, Templin MF, Joos TO, Marcus K, Poetz O.

Sci Rep. 2015 Mar 4;5:8759. doi: 10.1038/srep08759.

12.

Kinase analysis in alcoholic hepatitis identifies p90RSK as a potential mediator of liver fibrogenesis.

Morales-Ibanez O, Affò S, Rodrigo-Torres D, Blaya D, Millán C, Coll M, Perea L, Odena G, Knorpp T, Templin MF, Moreno M, Altamirano J, Miquel R, Arroyo V, Ginès P, Caballería J, Sancho-Bru P, Bataller R.

Gut. 2016 May;65(5):840-51. doi: 10.1136/gutjnl-2014-307979. Epub 2015 Feb 4.

13.

RPPApipe: a pipeline for the analysis of reverse-phase protein array data.

Eichner J, Heubach Y, Ruff M, Kohlhof H, Strobl S, Mayer B, Pawlak M, Templin MF, Zell A.

Biosystems. 2014 Aug;122:19-24. doi: 10.1016/j.biosystems.2014.06.009. Epub 2014 Jun 18.

PMID:
24951946
14.

Cross-platform toxicogenomics for the prediction of non-genotoxic hepatocarcinogenesis in rat.

Römer M, Eichner J, Metzger U, Templin MF, Plummer S, Ellinger-Ziegelbauer H, Zell A.

PLoS One. 2014 May 15;9(5):e97640. doi: 10.1371/journal.pone.0097640. eCollection 2014.

15.

Ha-ras and β-catenin oncoproteins orchestrate metabolic programs in mouse liver tumors.

Unterberger EB, Eichner J, Wrzodek C, Lempiäinen H, Luisier R, Terranova R, Metzger U, Plummer S, Knorpp T, Braeuning A, Moggs J, Templin MF, Honndorf V, Piotto M, Zell A, Schwarz M.

Int J Cancer. 2014 Oct 1;135(7):1574-85. doi: 10.1002/ijc.28798. Epub 2014 Mar 3.

16.

Multiple protein analysis of formalin-fixed and paraffin-embedded tissue samples with reverse phase protein arrays.

Assadi M, Lamerz J, Jarutat T, Farfsing A, Paul H, Gierke B, Breitinger E, Templin MF, Essioux L, Arbogast S, Venturi M, Pawlak M, Langen H, Schindler T.

Mol Cell Proteomics. 2013 Sep;12(9):2615-22. doi: 10.1074/mcp.M112.023051. Epub 2013 May 7.

17.

From spots to beads-PTM-peptide bead arrays for the characterization of anti-histone antibodies.

Heubach Y, Planatscher H, Sommersdorf C, Maisch D, Maier J, Joos TO, Templin MF, Poetz O.

Proteomics. 2013 Mar;13(6):1010-5. doi: 10.1002/pmic.201200383.

PMID:
23401470
18.

Identification of Dlk1-Dio3 imprinted gene cluster noncoding RNAs as novel candidate biomarkers for liver tumor promotion.

Lempiäinen H, Couttet P, Bolognani F, Müller A, Dubost V, Luisier R, Del Rio Espinola A, Vitry V, Unterberger EB, Thomson JP, Treindl F, Metzger U, Wrzodek C, Hahne F, Zollinger T, Brasa S, Kalteis M, Marcellin M, Giudicelli F, Braeuning A, Morawiec L, Zamurovic N, Längle U, Scheer N, Schübeler D, Goodman J, Chibout SD, Marlowe J, Theil D, Heard DJ, Grenet O, Zell A, Templin MF, Meehan RR, Wolf RC, Elcombe CR, Schwarz M, Moulin P, Terranova R, Moggs JG.

Toxicol Sci. 2013 Feb;131(2):375-86. doi: 10.1093/toxsci/kfs303. Epub 2012 Oct 22.

PMID:
23091169
19.

A comprehensive small interfering RNA screen identifies signaling pathways required for gephyrin clustering.

Wuchter J, Beuter S, Treindl F, Herrmann T, Zeck G, Templin MF, Volkmer H.

J Neurosci. 2012 Oct 17;32(42):14821-34. doi: 10.1523/JNEUROSCI.1261-12.2012.

20.

Combining ultracentrifugation and peptide termini group-specific immunoprecipitation for multiplex plasma protein analysis.

Volk S, Schreiber TD, Eisen D, Wiese C, Planatscher H, Pynn CJ, Stoll D, Templin MF, Joos TO, Pötz O.

Mol Cell Proteomics. 2012 Jul;11(7):O111.015438. doi: 10.1074/mcp.O111.015438. Epub 2012 Apr 23.

21.

New insight on a possible mechanism of progestogens in terms of breast cancer risk.

Neubauer H, Chen R, Schneck H, Knorrp T, Templin MF, Fehm T, Cahill MA, Seeger H, Yu Q, Mueck AO.

Horm Mol Biol Clin Investig. 2011 Apr 1;6(1):185-92. doi: 10.1515/HMBCI.2010.082.

PMID:
25961254
22.

Targeting peptide termini, a novel immunoaffinity approach to reduce complexity in mass spectrometric protein identification.

Hoeppe S, Schreiber TD, Planatscher H, Zell A, Templin MF, Stoll D, Joos TO, Poetz O.

Mol Cell Proteomics. 2011 Feb;10(2):M110.002857. doi: 10.1074/mcp.M110.002857. Epub 2010 Oct 20.

23.

Sequential multiplex analyte capturing for phosphoprotein profiling.

Poetz O, Henzler T, Hartmann M, Kazmaier C, Templin MF, Herget T, Joos TO.

Mol Cell Proteomics. 2010 Nov;9(11):2474-81. doi: 10.1074/mcp.M110.002709. Epub 2010 Aug 3.

24.

Optimal selection of epitopes for TXP-immunoaffinity mass spectrometry.

Planatscher H, Supper J, Poetz O, Stoll D, Joos T, Templin MF, Zell A.

Algorithms Mol Biol. 2010 Jun 25;5:28. doi: 10.1186/1748-7188-5-28.

25.

Novel functional profiling approach combining reverse phase protein microarrays and human 3-D ex vivo tissue cultures: expression of apoptosis-related proteins in human colon cancer.

Pirnia F, Pawlak M, Thallinger GG, Gierke B, Templin MF, Kappeler A, Betticher DC, Gloor B, Borner MM.

Proteomics. 2009 Jul;9(13):3535-48. doi: 10.1002/pmic.200800159.

PMID:
19609961
26.

Proteome wide screening using peptide affinity capture.

Poetz O, Hoeppe S, Templin MF, Stoll D, Joos TO.

Proteomics. 2009 Mar;9(6):1518-23. doi: 10.1002/pmic.200800842. Review.

PMID:
19294621
27.

On display on a bug: a systematic approach to characterize antibodies.

Knorpp T, Templin MF.

Nat Methods. 2008 Dec;5(12):1003-4. doi: 10.1038/nmeth1208-1003. No abstract available. Erratum in: Nat Methods. 2008 Dec;5(12):109. Nat Methods. 2009 Jan;6(1):109.

PMID:
19034267
28.

Protein microarrays for diagnostic assays.

Hartmann M, Roeraade J, Stoll D, Templin MF, Joos TO.

Anal Bioanal Chem. 2009 Mar;393(5):1407-16. doi: 10.1007/s00216-008-2379-z. Epub 2008 Sep 20. Review.

PMID:
18807017
29.

Expanding assay dynamics: a combined competitive and direct assay system for the quantification of proteins in multiplexed immunoassays.

Hartmann M, Schrenk M, Döttinger A, Nagel S, Roeraade J, Joos TO, Templin MF.

Clin Chem. 2008 Jun;54(6):956-63. doi: 10.1373/clinchem.2007.099812. Epub 2008 Apr 24.

30.

Protein microarrays.

Kramer S, Joos TO, Templin MF.

Curr Protoc Protein Sci. 2005 Mar;Chapter 23:Unit 23.5. doi: 10.1002/0471140864.ps2305s39.

PMID:
18429284
31.

Tumor promotion in liver of mice with a conditional Cx26 knockout.

Marx-Stoelting P, Mahr J, Knorpp T, Schreiber S, Templin MF, Ott T, Buchmann A, Schwarz M.

Toxicol Sci. 2008 Jun;103(2):260-7. doi: 10.1093/toxsci/kfn043. Epub 2008 Feb 27.

PMID:
18308698
32.

Secretion of matrix metalloproteinase 3 by expanded articular chondrocytes as a predictor of ectopic cartilage formation capacity in vivo.

Pelttari K, Lorenz H, Boeuf S, Templin MF, Bischel O, Goetzke K, Hsu HY, Steck E, Richter W.

Arthritis Rheum. 2008 Feb;58(2):467-74. doi: 10.1002/art.23302.

33.

Increasing robustness and sensitivity of protein microarrays through microagitation and automation.

Hartmann M, Toegl A, Kirchner R, Templin MF, Joos TO.

Anal Chim Acta. 2006 Mar 30;564(1):66-73. Epub 2006 Feb 21.

PMID:
17723363
34.

Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins.

Waterboer T, Sehr P, Michael KM, Franceschi S, Nieland JD, Joos TO, Templin MF, Pawlita M.

Clin Chem. 2005 Oct;51(10):1845-53. Epub 2005 Aug 11.

35.

Protein microarrays for antibody profiling: specificity and affinity determination on a chip.

Poetz O, Ostendorp R, Brocks B, Schwenk JM, Stoll D, Joos TO, Templin MF.

Proteomics. 2005 Jun;5(9):2402-11.

PMID:
15887189
36.

Protein microarrays: applications and future challenges.

Stoll D, Templin MF, Bachmann J, Joos TO.

Curr Opin Drug Discov Devel. 2005 Mar;8(2):239-52. Review.

PMID:
15782547
37.

Protein microarrays: catching the proteome.

Poetz O, Schwenk JM, Kramer S, Stoll D, Templin MF, Joos TO.

Mech Ageing Dev. 2005 Jan;126(1):161-70. Review.

PMID:
15610775
38.

Microarray technology: an increasing variety of screening tools for proteomic research.

Stoll D, Bachmann J, Templin MF, Joos TO.

Drug Discov Today. 2004 Dec 15;9(24 Suppl):S10-7. Review.

PMID:
23573654
39.

Protein microarrays and multiplexed sandwich immunoassays: what beats the beads?

Templin MF, Stoll D, Bachmann J, Joos TO.

Comb Chem High Throughput Screen. 2004 May;7(3):223-9. Review.

PMID:
15134528
40.

Protein microarrays: promising tools for proteomic research.

Templin MF, Stoll D, Schwenk JM, Pötz O, Kramer S, Joos TO.

Proteomics. 2003 Nov;3(11):2155-66. Review.

PMID:
14595815
41.

Protein microarray technology.

Templin MF, Stoll D, Schrenk M, Traub PC, Vöhringer CF, Joos TO.

Drug Discov Today. 2002 Aug 1;7(15):815-22. Review.

PMID:
12546969
42.

Cell microarrays: an emerging technology for the characterization of antibodies.

Schwenk JM, Stoll D, Templin MF, Joos TO.

Biotechniques. 2002 Dec;Suppl:54-61.

PMID:
12514930
43.

Protein microarray technology.

Templin MF, Stoll D, Schrenk M, Traub PC, Vöhringer CF, Joos TO.

Trends Biotechnol. 2002 Apr;20(4):160-6. Review.

PMID:
11906748
44.

Miniaturised multiplexed immunoassays.

Joos TO, Stoll D, Templin MF.

Curr Opin Chem Biol. 2002 Feb;6(1):76-80. Review.

PMID:
11827827
45.

Protein microarray technology.

Stoll D, Templin MF, Schrenk M, Traub PC, Vöhringer CF, Joos TO.

Front Biosci. 2002 Jan 1;7:c13-32. Review.

PMID:
11779717
46.

Involvement of N-acetylmuramyl-L-alanine amidases in cell separation and antibiotic-induced autolysis of Escherichia coli.

Heidrich C, Templin MF, Ursinus A, Merdanovic M, Berger J, Schwarz H, de Pedro MA, Höltje JV.

Mol Microbiol. 2001 Jul;41(1):167-78.

48.
49.

Membrane-bound lytic endotransglycosylase in Escherichia coli.

Kraft AR, Templin MF, Höltje JV.

J Bacteriol. 1998 Jul;180(13):3441-7.

50.

Outer membrane localization of murein hydrolases: MltA, a third lipoprotein lytic transglycosylase in Escherichia coli.

Lommatzsch J, Templin MF, Kraft AR, Vollmer W, Höltje JV.

J Bacteriol. 1997 Sep;179(17):5465-70.

Supplemental Content

Loading ...
Support Center